Physician profile
Navin Singh
NPI 1225068786
$15,968.14
in general payments reported to CMS, 2019-2025
20 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,942 · 2020: $566 · 2021: $664 · 2022: $1,848 · 2023: $4,032 · 2024: $1,002 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,824 · Consulting Fee: $2,000 · Travel and Lodging: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,823.55 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $125.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $7,026.05 | 2019-2022 | |
| Smith+Nephew, INC. | $2,853.02 | 2019-2025 | Grafix, Grafix Pl, Stravix |
| Tela Bio, INC. | $2,324.92 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $910.47 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $446.25 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Innovation Technologies INC | $375.49 | 2020-2023 | Irrisept |
| Depuy Synthes Sales INC. | $277.26 | 2020-2024 | Matrixmandible, Trumatch |
| Baxter Healthcare | $267.29 | 2020-2024 | |
| Mentor Worldwide LLC | $256.17 | 2021-2023 | Mentor Siltex Round Spectrum |
| Access Pro Medical, LLC | $190.91 | 2025 | Matriderm |
| Motiva USA, LLC | $160.49 | 2025 | |
| Convatec INC. | $134.79 | 2023 | |
| Coopersurgical, INC. | $134.44 | 2019 | |
| Avita Medical Americas, LLC | $118.10 | 2024 | |
| Revance Therapeutics, INC. | $111.39 | 2024-2025 | Daxxify |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $105.18 | 2021 | |
| Axogen | $89.93 | 2025 | |
| Galderma Laboratories, L.P. | $88.59 | 2022-2025 | Aklief |
| Biocircuit Technologies INC | $74.13 | 2024 | |
| Janssen Pharmaceuticals, INC | $23.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navin Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.